InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Explore the detailed record of transactions filed by Struthers Richard Scott, Chairman & CEO. Insider active across 1 companies, notably Crinetics Pharmaceuticals, Inc.. Cumulatively, 5 reports have been published. Total volume traded: €1.5m. The latest transaction was filed on 13 April 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations5 total
€575,71224,674 shares@ €23.33280.013% mcap38.5% of flow
Common Stock
SEC:0001209191-22-024531:0·
€496,24421,357 shares@ €23.23560.011% mcap33.2% of flow
Common Stock
SEC:0001209191-22-023722:0·
053,400 shares0
Common Stock
SEC:0001209191-22-015134:0·
€211,08510,000 shares@ €21.10850.0047% mcap100.0% of flow
Common stock
SEC:0001209191-21-055312·
€211,08510,000 shares@ €21.10850.0047% mcap14.1% of flow
Common stock
SEC:0001209191-21-055312:0·
5 of 5 declarations
About Struthers Richard Scott
Richard Scott Struthers is the Chief Executive Officer of Crinetics Pharmaceuticals, Inc. He leads the company with a focus on innovation in the pharmaceutical field. His leadership is essential for the development of new treatments and for the growth of Crinetics.
